With a track record of having been CEO and/or founder of several other firms and Associate Vice President For Research and Director, Technology Transfer, the president of Razi Pharma brings a diversity of relavent experience to the table. Indicated as a viable business since 2019, the firm itself has a very limited online presence with management describing the firm as an innovative bio-pharmaceutical company dedicated to developing innovative vaccines and treatments for infectious diseases and novel immuno-oncology therapies.
